Bone Metastases

Bone Metastases is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Metastases to bone · Bone Metastasis · Metastasis to Bone
Classified under: Musculoskeletal and Connective Tissue Diseases
Neoplasms
Signs, Symptoms, and General Pathologies
Indicated drugs: Denosumab
Ibandronate
Zoledronic acid

Resolves to

Vocabularies

ICD-10C79.5SNOMED CT154572002MedDRA10005993UMLSC0153690

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

100Clinical trialsPhase, status and sponsor resolved per trial

3Contraindicated drugsDrugs whose labels contraindicate them in this condition

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Bone Metastases share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.